Evaluating the performance of the InnowaveDx MTB/RIF/INH for simultaneous detection of Mycobacterium tuberculosis and resistance to rifampicin and isoniazid
The InnowaveDx MTB/RIF/INH assay demonstrates good performance in detecting M. tuberculosis as well as rifampicin and isoniazid resistance. The discrepancies in rifampicin-resistance results and phenotypic resistance are mainly the result of borderline resistance mutations.
Authors
- Xuechai Shang
- Dapeng Fan
- Hao Li (ORCID: https://orcid.org/0000-0002-4131-5207)
- Long Cai (ORCID: https://orcid.org/0000-0001-6585-2448)
- H Y Li
- Miaofen Yang
- Yongning Yue
Institutions
- Integrated Chinese Medicine (China) (HK)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.jgar.2025.12.016
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00